GRI: Volume dana dhuwit perusahaan GRI Bio

Simbol resmi perusahaan GRI Bio (GRI)

GRI Bio, Inc. (GRI) is diversifying its scientific risks by developing unique immunological treatments for fibrotic pathologies. This free cash flow chart confirms the current liquidity status, where the metric has reached the level of 0.01. The absence of regular sales ties the company's market capitalization to test results. The viability of the model relies on the successful safety validation of the drugs and securing investments to complete early-stage R&D.

Cadangan dhuwit perusahaan: GRI Bio Corporation (GRI) kanggo 21.02.2024 - 21.11.2026

Rincian analitis lan laporan data perusahaan GRI Bio Inc (GRI)

- kuotasi lan prakiraan analis:
Ringkesan analitik perusahaan:gribio.com
Produk merek GRI Bio

This indicator determines the volume of liquid assets that form the foundation of the issuer's solvency. For GRI Bio, Inc. (GRI), this is a critical metric, as the absence of sales and high R&D costs make the company dependent on its capital reserves. The trend in cash holdings clearly demonstrates the burn rate of resources on clinical trials. Analysis of this chart allows for an assessment of the risk of funding shortages when scaling the pipeline. A stable cash balance confirms the financial viability of the business.

Pesaing GRI Bio, Inc.

Volume dana dhuwit perusahaan ARGX|BioNTech - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan ABVX (abivax.com)|Sisa dhuwit perusahaan ADMA|Protagonist Therapeutics, Inc. - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Immunovant, Inc.|KNSA: Volume dana dhuwit perusahaan|GRFS - Aset likuid perusahaan|ADPT (Adaptive Biotechnologies Inc.) - Volume dana dhuwit perusahaan|CLDX: Sisa dhuwit perusahaan|Dana dhuwit perusahaan Aurinia Pharmaceuticals Inc. (AUPH)|Dana dhuwit perusahaan BCRX (BioCryst Pharmaceuticals Inc)|Volume dana dhuwit perusahaan VERA (Vera Corp)|Gunggung dana dhuwit perusahaan DNTH (Dianthus Therapeutics)|PHVS - Dana dhuwit perusahaan|ABCL: Dana dhuwit perusahaan|TRML: Volume dana dhuwit perusahaan|Dhuwit awis perusahaan Precigen, Inc.|Dhuwit awis perusahaan PHAR|Nektar Therapeutics - Total volume dana dhuwit perusahaan|Dana dhuwit perusahaan Upstream Bio Corp (UPB)|Dhuwit awis perusahaan Zenas Biopharma ZBIO|Dana dhuwit perusahaan Immunome Bio IMNM|GOSS: Dhuwit awis lan setara dhuwit awis perusahaan|kalvista.com - Volume dana dhuwit perusahaan|SEPN (septerna.com) - Dhuwit awis lan setara dhuwit awis perusahaan|PVLA (Pieris Pharmaceuticals) - Dhuwit awis perusahaan|Savara - Sisa dhuwit perusahaan|RIGL (Rigel Corp) - Volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan AnaptysBio Corp|Dana dhuwit perusahaan astriatx.com (ATXS)|Dhuwit awis perusahaan enGene ENGN|Dana dhuwit perusahaan RAPT Therapeutics, Inc. RAPT|JBIO - Dhuwit awis perusahaan|Aclaris Therapeutics Inc. - Volume dana dhuwit perusahaan|KYTX - Volume dana dhuwit perusahaan|TLSA (Tiziana Life Sciences PLC) - Dhuwit awis perusahaan|cabalettabio.com (CABA) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan Ventyx Biosciences|THTX (Theratechnologies) - Gunggung dana dhuwit perusahaan|Dhuwit awis perusahaan AVTX (Avalo Therapeutics Inc.)|Dana dhuwit perusahaan ELDN (Eledon)|Volume dana dhuwit perusahaan AGEN (Agenus, Inc)|Aset likuid perusahaan climbbio.com (CLYM)|zurabio.com - Volume dana dhuwit perusahaan|ATYR - Volume dana dhuwit perusahaan|ADAG: Volume dana dhuwit perusahaan|Ikena Oncology, Inc. (IMA) - Volume dana dhuwit perusahaan|STTK (Shattuck Therapeutics) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan equilliumbio.com EQ|Volume dana dhuwit perusahaan CNTB|IMUX - Cadangan dhuwit perusahaan|Dana dhuwit perusahaan Atara Biotherapeutics ATRA|Aset likuid perusahaan InflaRx N.V. (IFRX)|XFOR: Dhuwit awis perusahaan|adicetbio.com (ACET) - Dhuwit awis perusahaan|CELU: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan INmune Bio (INMB)|Dana dhuwit perusahaan Barinthus Bio|Dhuwit awis lan setara dhuwit awis perusahaan KZR (Kezar Life Sciences, Inc)|Dhuwit awis perusahaan SABS (SAB Biotherapeutics Inc)|Akari Therapeutics - Dhuwit awis lan setara dhuwit awis perusahaan|Enlivex Therapeutics Ltd - Dhuwit awis perusahaan|Sisa dhuwit perusahaan QTTB|GOVX - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan Edesa|IBIO: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Carisma Therapeutics Inc (CARM)|Dana dhuwit perusahaan XTL Biopharmaceuticals, Ltd.|Dana dhuwit perusahaan BOLT|Dhuwit awis perusahaan HCWB (HCW Biologics, Inc.)|Gunggung dana dhuwit perusahaan APVO|AIM ImmunoTech - Dhuwit awis perusahaan|Sisa dhuwit perusahaan ADTX|XRTX: Dhuwit awis perusahaan|Sisa dhuwit perusahaan HIND (Vyome Holdings)|REVB (Revelation Bio) - Dhuwit awis perusahaan|Indaptus Corp (INDP) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan scinai.com|Dhuwit awis perusahaan CalciMedica, Inc. (CALI)|Dana dhuwit perusahaan Affimed NV (AFMD)|Dana dhuwit perusahaan ALLK (Allakos Inc)|Dana dhuwit perusahaan HOOKIPA Pharma, Inc. HOOK|Aset likuid perusahaan IGM Bio (IGMS)|iTeos Pharma - Volume dana dhuwit perusahaan|Aset likuid perusahaan oceanbiomedical.com OCEA|TC BioPharm (TCBP) - Dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan THRD